171 related articles for article (PubMed ID: 10643443)
1. The first miracle in neurodegenerative disease: the discovery of oral levodopa.
Kordower JH; Goetz CG
Brain Res Bull; 1999; 50(5-6):377-8. PubMed ID: 10643443
[No Abstract] [Full Text] [Related]
2. Levodopa: 50 years of a revolutionary drug for Parkinson disease.
Fahn S; Poewe W
Mov Disord; 2015 Jan; 30(1):1-3. PubMed ID: 25488146
[No Abstract] [Full Text] [Related]
3. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
Titova NV; Katunina EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973
[No Abstract] [Full Text] [Related]
4. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Nutt JG
Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
[No Abstract] [Full Text] [Related]
5. L-DOPA.
Hornykiewicz O
J Parkinsons Dis; 2017; 7(s1):S3-S10. PubMed ID: 28282813
[No Abstract] [Full Text] [Related]
6. The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
Birkmayer W; Hornykiewicz O
Wien Klin Wochenschr; 2001 Nov; 113(22):851-4. PubMed ID: 11763859
[No Abstract] [Full Text] [Related]
7. [L-dopa: a fascinating history].
García de Yébenes J; García Ruiz P
Neurologia; 1998; 13 Suppl 1():36-40. PubMed ID: 9859684
[No Abstract] [Full Text] [Related]
8. [Madopar: more than 20 years].
Leiva C
Rev Neurol; 1997 Dec; 25(148):1957-63. PubMed ID: 9528041
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease. A half century of progress.
Jankovic J
Neurology; 2001 Nov; 57(10 Suppl 3):S1-3. PubMed ID: 11771154
[No Abstract] [Full Text] [Related]
10. [Short history of L-Dopa].
García Ruiz PJ; Meseguer E
Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
[TBL] [Abstract][Full Text] [Related]
11. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
Rinne UK
Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
[No Abstract] [Full Text] [Related]
12. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Deleu D; Hanssens Y
Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16721952
[No Abstract] [Full Text] [Related]
13. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago.
Hornykiewicz O
Wien Klin Wochenschr; 2001 Nov; 113(22):855-62. PubMed ID: 11762121
[No Abstract] [Full Text] [Related]
14. 50 years of levodopa.
Hornykiewicz O
Mov Disord; 2015 Jun; 30(7):1008. PubMed ID: 25999218
[No Abstract] [Full Text] [Related]
15. Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s.
Santos-Lobato BL; Tumas V
Arq Neuropsiquiatr; 2016 Aug; 74(8):687-9. PubMed ID: 27556381
[TBL] [Abstract][Full Text] [Related]
16. [Current possibilities of quality of life improvement in the late stages of Parkinson's disease].
Titova NV; Katunina EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):94-100. PubMed ID: 26171484
[TBL] [Abstract][Full Text] [Related]
17. Oral formulations of L-dopa and continuous dopaminergic stimulation.
Iansek R; Danoudis M
Mov Disord; 2012 Apr; 27(4):579. PubMed ID: 22344707
[No Abstract] [Full Text] [Related]
18. Reply: Oleh Hornykiewicz's contribution to the l-dopa story.
Fahn S
Mov Disord; 2015 Jun; 30(7):1008-9. PubMed ID: 25880230
[No Abstract] [Full Text] [Related]
19. [Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):21-4. PubMed ID: 14681961
[TBL] [Abstract][Full Text] [Related]
20. History of levodopa and dopamine agonists in Parkinson's disease treatment.
Tolosa E; Martí MJ; Valldeoriola F; Molinuevo JL
Neurology; 1998 Jun; 50(6 Suppl 6):S2-10; discussion S44-8. PubMed ID: 9633679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
